opioid Archives
Artificial intelligence predicts opioid overdose in Tennessee
Oct. 19, 2021—Researchers at Vanderbilt and the Tennessee Department of Health have developed 30-day predictive models for fatal and non-fatal opioid-related overdose among patients receiving opioid prescriptions in the state.
Study finds increased risk of serious opioid events in mothers, regardless of dose
Apr. 26, 2021—A new study from Vanderbilt University Medical Center researchers finds that new mothers who receive opioids after uncomplicated vaginal births face an increased risk of serious opioid-related events regardless of the opioid dosage, a finding that could significantly impact care delivery.
Codeine metabolizer status in clinical practice
Apr. 5, 2021—Vanderbilt researchers have developed a response score using genetic and clinical information to aid prescribing of the widely used pain medication codeine.
Program using telehealth to treat Opioid Use Disorder
Feb. 11, 2021—The Vanderbilt Maternal Addiction Recovery Program (VMARP) is offering virtual appointments to help reach patients in Nashville’s outlying areas for treatment of Opioid Use Disorder (OUD).
Study shows drastic increases in opioid-affected births
Jan. 12, 2021—The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.
VA adopts enhanced recovery for total knee, total hip patients
Jan. 7, 2021—For patients receiving total knee or total hip replacements at the Nashville VA Medical Center, the use of opioids for inpatient pain management and the total time patients spent in the hospital were both greatly reduced following the January 2016 adoption of sweeping quality improvement measures.
Model helps predict which infants may go on to develop NAS
Nov. 12, 2020—A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.
Land of plenty (of opioids)
Aug. 24, 2020—Surgical patients are being given more opioids than they need for postsurgical pain management, raising the risk of addiction.
Study finds patients’ access to opioid treatment cumbersome
Aug. 14, 2020—Women are having a difficult time getting into treatment for opioid addictions, according to a Vanderbilt University Medical Center study published today in JAMA Open.
Acupressure studied to treat neonatal opioid withdrawal
Aug. 13, 2020—Researchers from Vanderbilt University Medical Center recently completed a study to create a standardized protocol for using acupressure to treat newborns with opioid withdrawal syndrome.
Patrick receives award for children’s health research
Aug. 6, 2020—Stephen Patrick, MD, MPH, MS, director of the Vanderbilt Center for Child Health Policy, has been awarded the fifth annual Gale and Ira Drukier Prize in Children’s Health Research.
Opioid prescriptions after childbirth linked to increased risk of overdose, persistent use
Jun. 9, 2020—Women who are prescribed opioids after childbirth have an increased risk of persistent opioid use or other serious opioid-related events, including overdose, in their first year postpartum, according to a new study by Vanderbilt University Medical Center researchers. This is true regardless of whether the woman had a vaginal delivery or a cesarean section.
